Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $4.1400 (-5.48%) ($4.1400 - $4.1400) on Tue. Dec. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.67% (three month average) | RSI | 45 | Latest Price | $4.1400(-5.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.4% a day on average for past five trading days. | Weekly Trend | CGEN declines -0.3% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(84%) ARKG(81%) ARKK(80%) IBUY(78%) IWO(77%) | Factors Impacting CGEN price | CGEN will decline at least -2.335% in a week (0% probabilities). VIXM(-67%) VXX(-50%) UUP(-19%) UNG(-14%) TLT(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.335% (StdDev 4.67%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $4.35 | 5 Day Moving Average | $4.4(-5.91%) | 10 Day Moving Average | $4.33(-4.39%) | 20 Day Moving Average | $4.35(-4.83%) | To recent high | -42.2% | To recent low | 1.7% | Market Cap | $342m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |